EU/US Properties Organoleptics Cosmetics Suppliers Safety Safety in use Safety references References Other Blenders Uses Occurrence Synonyms Articles Notes
 

bifidobacterium breve M-16V

Supplier Sponsors

Category:food additive
 
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Google Scholar:Search
Google Books:Search
Google Scholar: with word "volatile"Search
Google Scholar: with word "flavor"Search
Google Scholar: with word "odor"Search
Google Patents:Search
US Patents:Search
EU Patents:Search
PubMed:Search
NCBI:Search
 FDA/DG SANTE Petitions, Reviews, Notices:
GRN 455 Bifidobacterium breve M-16V View - notice PDF
GRN 454 Bifidobacterium breve M-16V View - notice PDF
GRN 453 Bifidobacterium breve M-16V View - notice PDF
 
Physical Properties:
Food Chemicals Codex Listed: No
 
Organoleptic Properties:
Odor and/or flavor descriptions from others (if found).
 
Cosmetic Information:
None found
 
Suppliers:
Chemical Sources Association
Need This Item for Flavor/Food?: You can contact the Chemical Sources Association
 
Safety Information:
 
Hazards identification
 
Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
None found.
GHS Label elements, including precautionary statements
 
Pictogram
 
Hazard statement(s)
None found.
Precautionary statement(s)
None found.
Oral/Parenteral Toxicity:
Not determined
Dermal Toxicity:
Not determined
Inhalation Toxicity:
Not determined
 
Safety in Use Information:
Category:
food additive
Recommendation for bifidobacterium breve M-16V usage levels up to:
 not for fragrance use.
 
Recommendation for bifidobacterium breve M-16V flavor usage levels up to:
 not for flavor use.
 
Safety References:
None found
 
References:
None found
 
Other Information:
FDA Substances Added to Food (formerly EAFUS):View
FDA Listing of Food Additive Status:View
Wikipedia:View
 
Potential Blenders and core components note
None Found
 
Potential Uses:
None Found
 
Occurrence (nature, food, other):note
 bifidobacterium breve
Search PMC Picture
 
Synonyms:
 bifidobacterium breve M-16V
 

Articles:

PubMed:The development of allergic inflammation in a murine house dust mite asthma model is suppressed by synbiotic mixtures of non-digestible oligosaccharides and Bifidobacterium breve M-16V.
PubMed:Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates--a randomised double blind placebo controlled trial.
PubMed:No detectable beneficial systemic immunomodulatory effects of a specific synbiotic mixture in infants with atopic dermatitis.
PubMed:Bifidobacterium breve alters immune function and ameliorates DSS-induced inflammation in weanling rats.
PubMed:Bifidobacterium breve prevents necrotising enterocolitis by suppressing inflammatory responses in a preterm rat model.
PubMed:Synbiotics-supplemented amino acid-based formula supports adequate growth in cow's milk allergic infants.
PubMed:Novel immunotherapy approaches to food allergy.
PubMed:Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota.
PubMed:Galectin-9 induced by dietary synbiotics is involved in suppression of allergic symptoms in mice and humans.
PubMed:Effect of administration of bifidobacteria on intestinal microbiota in low-birth-weight infants and transition of administered bifidobacteria: a comparison between one-species and three-species administration.
PubMed:Intestinal epithelium-derived galectin-9 is involved in the immunomodulating effects of nondigestible oligosaccharides.
PubMed:Effects of Bifidobacterium breve on inflammatory gene expression in neonatal and weaning rat intestine.
PubMed:Synbiotics prevent asthma-like symptoms in infants with atopic dermatitis.
PubMed:Synbiotics reduce allergen-induced T-helper 2 response and improve peak expiratory flow in allergic asthmatics.
PubMed:Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized-controlled trial.
PubMed:Safety evaluation of probiotic bifidobacteria by analysis of mucin degradation activity and translocation ability.
PubMed:Oral treatment with probiotics reduces allergic symptoms in ovalbumin-sensitized mice: a bacterial strain comparative study.
PubMed:Cow milk allergy symptoms are reduced in mice fed dietary synbiotics during oral sensitization with whey.
PubMed:Suppressive effects of bifidobacterium breve strain M-16V on T-helper type 2 immune responses in a murine model.
PubMed:[Effects of administration of bifidobacteria on fecal microflora and clinical symptoms in infants with atopic dermatitis].
PubMed:Effects of oral administration of bifidobacterium breve on fecal lactic acid and short-chain fatty acids in low birth weight infants.
 
Notes:
None found
Please share your Comments.
Email Address:
Top of Page Home
Copyright © 1980-2021 The Good Scents Company (tgsc) ™ Disclaimer Privacy Policy